NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1050210142

Registered date:25/12/2021

Evaluation of the effectiveness of a nursing support program to enhance family resilience in people with schizophrenia

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedschizophrenia
Date of first enrollment25/12/2021
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)This study aims to increase family resilience through interviews, social skills training, and psychoeducation by intervening in a nursing support program developed by the principal investigator for parents of persons with schizophrenia. The intervention will be individualized and the target population will be parents of persons with schizophrenia. The program takes less than one hour and consists of 40 minutes of interview and social skills training and 20 minutes of psychological education. The program consists of six sessions and is conducted once every four weeks in conjunction with the outpatient clinic for persons with schizophrenia . We will not intervene with the person with schizophrenia, but we will conduct a questionnaire survey with both the parent and the person with schizophrenia to determine if the intervention with the parent has an impact on the person with schizophrenia.

Outcome(s)

Primary OutcomeFamily Resilience: Family Resilience Inventory scale score
Secondary OutcomeGHQ28 score, salivary stress sensor amylase and cortisol levels

Key inclusion & exclusion criteria

Age minimum>= 16age old
Age maximumNot applicable
GenderBoth
Include criteriaThis study will be conducted on people with schizophrenia and their parents who meet all of the following criteria. In order to investigate whether the intervention of the nursing support program for parents also changes the family resilience of people with schizophrenia, we will ask both the individual and the parent to participate. People with schizophrenia 1. Age: 16 years or older at the time of obtaining consent 2. Gender: Any 3. Within 5 years of the initial diagnosis of schizophrenia 4. Those who have been approved by the attending physician to participate in the study on the grounds that they conform to the DSM-5 diagnosis and have sufficient judgment to participate in the study 5. Those who have received permission from their physician to participate in the study because they meet the DSM-5 diagnosis and have sufficient judgment Parents of persons with schizophrenia 1. Age: No question 2. Gender: Any 3. A parent who lives with the person with schizophrenia 4. Those who have received sufficient explanations about participation in this study and have given written consent of their own free will with full understanding.
Exclude criteria1. Those who have received psychological education or social skills training in the past 2. Pregnant 3. Others who are judged by the principal investigator to be inappropriate as research subjects after consultation with the attending physician of the person with schizophrenia

Related Information

Contact

Public contact
Name Megumi Kawaguchi
Address 23-3 Matsuokashimoaizuki, Eiheiji-cho Yoshida-Gun, Fukui Fukui Japan 910-1193
Telephone +81-776-61-3111
E-mail senmegu@u-fukui.ac.jp
Affiliation University of Fukui
Scientific contact
Name Megumi Kawaguchi
Address 23-3 Matsuokashimoaizuki, Eiheiji-cho Yoshida-Gun, Fukui Fukui Japan 910-1193
Telephone +81-776-61-3111
E-mail senmegu@u-fukui.ac.jp
Affiliation University of Fukui